scholarly journals Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival

2016 ◽  
Vol 140 (6) ◽  
pp. 1270-1279 ◽  
Author(s):  
Hongyu Li ◽  
Yanru Wang ◽  
Hongliang Liu ◽  
Qiong Shi ◽  
Yinghui Xu ◽  
...  
2018 ◽  
Vol 40 (2) ◽  
pp. 279-288 ◽  
Author(s):  
Xiaomeng Wang ◽  
Hongliang Liu ◽  
Yinghui Xu ◽  
Jichun Xie ◽  
Dakai Zhu ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (43) ◽  
pp. 74595-74606 ◽  
Author(s):  
Hong Li ◽  
Yanru Wang ◽  
Hongliang Liu ◽  
Qiong Shi ◽  
Hongyu Li ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Guillaume B. Cardin ◽  
Monique Bernard ◽  
Francis Rodier ◽  
Apostolos Christopoulos

AbstractGermline single nucleotide polymorphisms in the promoter region of the DCBLD1 gene are associated with non-smoking cases of both non-small cell lung carcinoma (NSCLC) and human papillomavirus-negative head and neck cancer. However the clinical relevance and function of DCBLD1 remain unclear. This multicenter retrospective study was designed to evaluate the prognostic value and function of DCBLD1 in the four main solid cancers: NSCLC, invasive breast carcinoma, colorectal adenocarcinoma and prostate adenocarcinoma. We included the following cohorts: GSE81089 NSCLC, METABRIC invasive breast carcinoma, GSE14333 colorectal adenocarcinoma, GSE70770 prostate adenocarcinoma and The Cancer Genome Atlas (TCGA) Firehose Legacy cohorts of all four cancers. DCBLD1 gene expression was associated with a worse overall survival in multivariate analyses for both NSCLC cohorts (TCGA: P = 0.03 and GSE81089: P = 0.04) and both invasive breast carcinoma cohorts (TCGA: P = 0.02 and METABRIC: P < 0.001). Patients with high DCBLD1 expression showed an upregulation of the integrin signaling pathway in comparison to those with low DCBLD1 expression in the TCGA NSCLC cohort (FDR = 5.16 × 10–14) and TCGA invasive breast carcinoma cohort (FDR = 1.94 × 10–05).


2021 ◽  
Author(s):  
Yuanmin He ◽  
Hongliang Liu ◽  
Sheng Luo ◽  
Christopher I. Amos ◽  
Jeffrey E. Lee ◽  
...  

2007 ◽  
Vol 23 (4) ◽  
pp. 229-235 ◽  
Author(s):  
Yu-Zhen Gao ◽  
Shi-Yu Guo ◽  
Qi-Zhang Yin ◽  
Xiang-Qin Cui ◽  
Tadashi Hisamitsu ◽  
...  

2020 ◽  
Vol 59 (8) ◽  
pp. 930-939
Author(s):  
Xiaowen Liu ◽  
Danwen Qian ◽  
Hongliang Liu ◽  
James L. Abbruzzese ◽  
Sheng Luo ◽  
...  

2000 ◽  
Vol 88 (1) ◽  
pp. 337-343 ◽  
Author(s):  
James A. Carson ◽  
Lei Wei

Overloaded skeletal muscle undergoes dramatic shifts in gene expression, which alter both the phenotype and mass. Molecular biology techniques employing both in vivo and in vitro hypertrophy models have demonstrated that mechanical forces can alter skeletal muscle gene regulation. This review's purpose is to support integrin-mediated signaling as a candidate for mechanical load-induced hypertrophy. Research quantifying components of the integrin-signaling pathway in overloaded skeletal muscle have been integrated with knowledge regarding integrins role during development and cardiac hypertrophy, with the hope of demonstrating the pathway's importance. The role of integrin signaling as an integrator of mechanical forces and growth factor signaling during hypertrophy is discussed. Specific components of integrin signaling, including focal adhesion kinase and low-molecular-weight GTPase Rho are mentioned as downstream targets of this signaling pathway. There is a need for additional mechanistic studies capable of providing a stronger linkage between integrin-mediated signaling and skeletal muscle hypertrophy; however, there appears to be abundant justification for this type of research.


2013 ◽  
Author(s):  
Enping Xu ◽  
Karen H. Lu ◽  
Michelle AT Hildebrandt ◽  
Maosheng Huang ◽  
Xifeng Wu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document